2 completed, 1 unknown. 2 Phase 2, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
Follow Amirhossein Farahmand: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CoQ10 and Omega-3 as Adjuncts to Periodontal Therapy, TAC of Saliva. Receive 30 mg of Coq10, Non-Medicare Drugs - Periodontal Diseases | Not applicable | Unknown | Amirhossein Farahmand | 80 | 2024-02-20 | 2024-04-17 |
| Teh Effect of Subgingival Irrigation Wif Ketorolac and Chlorhexidine in Patients Wif Chronic Periodontist Ketorolac, Chlorhexidine 2% - Chronic Periodontitis | Phase 2 / Phase 3 | Completed | Amirhossein Farahmand | 2 | 2018-04-10 | 2019-07-05 |
| The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ® Doxycycline Group, placebo topical gel - Diabetes Mellitus With Periodontal Disease | Phase 2 / Phase 3 | Completed | Amirhossein Farahmand | 24 | 2015-01-01 | 2019-07-05 |
Chronic Periodontitis (1) · Periodontal Diseases (1)
Control Groups (1) · Docosahexaenoic Acids (1) · Doxycycline (1) · Gels (1) · Ketorolac (1) · coenzyme Q10 (1)
Iran (2)